image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 124.73
-12.4 %
$ 6.99 B
Market Cap
-4157.67
P/E
CASH FLOW STATEMENT
114 M OPERATING CASH FLOW
-33.80%
-123 M INVESTING CASH FLOW
47.15%
249 M FINANCING CASH FLOW
1966.69%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Repligen Corporation
image
Net Income 41.6 M
Depreciation & Amortization 68.1 M
Capital Expenditures -39 M
Stock-Based Compensation 25.6 M
Change in Working Capital -8.64 M
Others -51.5 M
Free Cash Flow 74.9 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000 Mar-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992 Mar-1991
OPERATING CASH FLOW
Net Income 41.6 186.0 128.3 59.9 21.4 16.6 28.4 11.7 9.3 8.2 16.1 14.2 43.5 K (4.1) 5.7 37.1 (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7)
Depreciation & Amortization 68.1 51.0 38.4 27.1 20.9 15.8 10.5 5.3 4.6 4.0 3.1 3.5 1.7 1.4 1.1 0.8 0.5 0.4 0.8 0.9 0.8 0.3 0.3 0.3 0.3 0.2 0.2 1.4 2.6 2.4 1.7 1.1 0.9
Deferred Income Tax 2.3 (1.4) 6.5 (4.0) (0.6) 71 K (24.7) (4.1) (0.1) 0.3 2.8 (3.1) 49.1 K 0 0 (524.4) 0 (20.6) (23.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 25.6 27.3 27.5 17.0 12.8 10.2 6.7 4.6 3.6 1.8 1.1 1.0 1.0 1.0 0.8 524.4 524.4 20.6 23.6 23.6 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities (15.0) (27.0) 20.4 11.2 13.8 4.2 4.0 5.5 4.1 2.1 93 K 0.3 43.5 K 905 6.12 K 0.8 0.8 0.1 3.6 K 2.6 91.3 K 0 0.4 0.2 0.9 100 K 0.5 2.7 5.2 100 K 0.4 6.0 0
Change in Working Capital (8.6) (63.8) (102.1) (48.6) (1.1) (14.1) (7.5) (15.5) (6.5) 2.0 2.8 (2.4) 0.6 (0.8) (1.3) (0.3) 80.8 K (0.8) 1.4 0.4 (1.6) (0.6) 20.8 K 0.2 100 K (0.2) (3.4) (1.9) 9.6 (7.8) 7.3 (2.9) (0.9)
Cash From Operations 113.9 172.1 119.0 62.6 67.2 32.8 17.5 7.5 15.1 18.4 25.9 13.4 3.2 (2.4) 6.3 38.5 0.4 0.4 (0.8) (5.7) (5.3) (4.8) (4.6) (3.1) (1.2) (0.7) (3.2) (9.3) (14.6) (24.8) (1.9) (8.6) (5.7)
INVESTING CASH FLOW
Capital Expenditures (39.0) (133.3) (71.3) (26.3) (23.2) (14.0) (5.5) (4.3) (2.6) (5.6) (4.6) (1.3) (0.5) (0.6) (1.3) (1.1) (1.3) (0.7) 52.7 K (0.3) (1.1) (0.3) (0.2) (0.2) (0.3) 100 K (0.4) (0.5) (0.6) 0 (18.2) (1.3) (1.1)
Other Items (84.3) (99.9) (149.9) (175.0) (182.2) 0 (92.8) (44.9) 7.4 (14.2) (13.3) 4.1 (1.0) 10.5 (30.9) (13.1) 3.1 2.2 80.2 K (8.1) 3.8 (2.4) (4.9) (8.8) 0 100 K 0.2 7.1 0 4.0 (2.6) (5.9) 2.4
Cash From Investing Activities (123.3) (233.2) (221.2) (201.4) (205.3) (14.0) (98.2) (49.2) 4.8 (19.8) (17.9) 2.8 (1.5) 9.9 (32.2) (14.2) 1.8 1.5 27.6 K (8.4) 2.7 (2.7) (5.1) (9.0) (0.3) 0 (0.2) 6.6 (0.6) 4.0 (20.8) (7.2) 1.3
FINANCING CASH FLOW
Common Stock Repurchased (14.4) (17.0) (2.9) 0 0 0 0 0 0 0 0 0 0 0 (2.0) (2.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 290.1 26 K 0 0 163.5 11 K 0 111.1 0 0 0 0 0 56.8 K 42.4 K 42.9 K 40 K 40 K 7.61 K 4.8 K 0 0 0 0 0 0 0 0 (4.6) 0 0 4.6 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (26.7) 3.7 3.9 8.1 0.7 3.4 0.6 1.0 0.8 431 72 K 1.2 0 6.57 K (1.6) 0.4 0 0 0 25.7 0 14.1 K 0 33.4 0 2.0 0 (4.2) 0 0.4 0.5 11.1 (13.2)
Cash From Financing Activities 249.0 (13.3) 1.0 305.9 484.9 3.4 129.9 112.1 0.8 1.7 2.5 1.2 50.3 K 11.6 K (1.6) 0.6 0.1 0.3 25.7 K 12.0 0 14.1 K 0.7 34.1 0 2.0 0 (4.2) 0.8 17.9 21.9 24.6 11.4
CHANGE IN CASH
Net Change In Cash 227.9 (80.4) (113.5) 179.9 343.6 20.1 51.5 68.1 18.7 (4.5) 10.6 18.0 1.7 7.5 (27.5) 24.8 2.3 2.2 (0.7) (2.1) (2.6) (7.5) (9.1) 22.0 (1.5) 1.3 (3.4) (6.9) (14.4) (2.9) (0.8) 8.8 7.0
FREE CASH FLOW
Free Cash Flow 74.9 38.7 47.7 36.3 44.1 18.7 12.0 3.2 12.4 12.8 21.3 12.2 2.7 (3.0) 5.0 37.4 (0.9) (0.3) (0.8) (6.0) (6.3) (5.1) (4.8) (3.4) (1.5) (0.8) (3.6) (9.8) (15.2) (24.8) (20.1) (9.9) (6.8)